Urea kinetic modeling for CRRT

被引:24
作者
Garred, L
Leblanc, M
Canaud, B
机构
[1] HOP MAISON NEUVE ROSEMONT,DEPT NEPHROL,MONTREAL,PQ H1T 2M4,CANADA
[2] HOP MAISON NEUVE ROSEMONT,DEPT INTENS CARE,MONTREAL,PQ H1T 2M4,CANADA
[3] LAPEYRONIE UNIV HOSP,SERV NEPHROL,MONTPELLIER,FRANCE
关键词
urea kinetic modeling; continuous renal replacement therapy; acute renal failure;
D O I
10.1016/S0272-6386(97)90535-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Urea kinetic modeling (UKM) for dialysis quantification and prescription, although widely used in chronic renal failure (CRF), has been largely absent in the acute setting, A quantitative approach to prescription of continuous renal replacement therapies (CRRTs) for acute renal failure (ARF) based on UKM is presented. For patients with a relatively constant urea generation rate, G, who are receiving a fixed dose of CRRT, blood urea nitrogen (BUN) falls in an exponential fashion, approaching a plateau level after 3 to 4 days of continuous treatment, The CRRT clearance, K, necessary to achieve a desired plateau value of BUN, C-goal, may be computed as O/C-goal x K for all but predilutional CRRT modalities may be calculated as equal to the effluent (dialysate plus ultrafiltrate) flow rate from the filter, Urea mass balance equations are proposed for the determination of patient G value either during the pretreatment rise in BUN or during the decline in BUN with CRRT, In the absence of a reliable estimate of patient G, a reasonable CRRT starting prescription is to set the filter effluent rate in liters per hour (approximate to K) to 1.2 times the patient's body weight in kilograms divided by the desired C-goal in milligrams per deciliter, This relationship assumes moderate hypercatabolism (normalized protein catabolic rate = 2.0 g/kg/d) and patient urea distribution Volume equal to 60% of body weight, For G(goal) = 60 mg/dL, this reduces to an easily remembered formula for K (in L/hr) of twice the patient's body weight divided by 100. (C) 1997 by the National Kidney Foundation, Inc.
引用
收藏
页码:S2 / S9
页数:8
相关论文
共 18 条
  • [1] Nomenclature for continuous renal replacement therapies
    Bellomo, R
    Ronco, C
    Mehta, RL
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (05) : S2 - S7
  • [2] SOLUTE CLEARANCES WITH HIGH DIALYSATE FLOW-RATES AND GLUCOSE-ABSORPTION FROM THE DIALYSATE IN CONTINUOUS ARTERIOVENOUS HEMODIALYSIS
    BONNARDEAUX, A
    PICHETTE, V
    OUIMET, D
    GEADAH, D
    HABEL, F
    CARDINAL, J
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (01) : 31 - 38
  • [3] NITROGEN-BALANCE DURING INTERMITTENT DIALYSIS THERAPY OF UREMIA
    BORAH, MF
    SCHOENFELD, PY
    GOTCH, FA
    SARGENT, JA
    WOLFSON, M
    HUMPHREYS, MH
    [J]. KIDNEY INTERNATIONAL, 1978, 14 (05) : 491 - 500
  • [4] Canaud B, 1988, Kidney Int Suppl, V24, pS154
  • [5] CHIMA CS, 1993, J AM SOC NEPHROL, V3, P1516
  • [6] Clark W R, 1992, ASAIO J, V38, pM664, DOI 10.1097/00002480-199207000-00120
  • [7] Solute control by extracorporeal therapies in acute renal failure
    Clark, WR
    Mueller, BA
    Kraus, MA
    Macias, WL
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (05) : S21 - S27
  • [8] Clark WR, 1997, J AM SOC NEPHROL, V8, P804
  • [9] UREA REMOVAL DURING CONTINUOUS HEMODIAFILTRATION
    FRANKENFIELD, DC
    REYNOLDS, HN
    WILES, CE
    BADELLINO, MM
    SIEGEL, JH
    [J]. CRITICAL CARE MEDICINE, 1994, 22 (03) : 407 - 412
  • [10] GARRED LJ, IN PRESS CRITICAL CA